Huakang Biomedical (08622) Announces January 2026 Monthly Return
Bulletin Express
Feb 03
Huakang Biomedical Holdings Company Limited (stock code: 08622) has released its monthly return for January 2026. According to the filing, the authorized share capital remains 1,000,000,000 ordinary shares at a par value of HKD 0.01 each, amounting to HKD 10,000,000 in total, with no change from the previous month.
The total number of issued shares also remains at 515,472,000. No movement was recorded in issued shares, treasury shares, or any convertible instruments. The company confirms that the minimum public float threshold of 25% has been met as of the end of January 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.